regulatory approval

News

Woman with vitiligo crosses her arms in front of her chest

Pfizer cues up vitiligo filing for Litfulo after phase 3 win

Pfizer's JAK inhibitor Litfulo hits the mark in vitiligo, setting up filings, as Incyte claims EU approval for Opzelura in atopic dermatitis.

News

EU first to clear AbbVie's Rinvoq for alopecia areata

AbbVie's fast-growing JAK inhibitor Rinvoq has been cleared for alopecia areata in the EU, its first market for the hair loss disorder.

News

Outlook finally claims FDA approval for AMD drug

After three knockbacks by the FDA, Outlook has finally pushed its therapy for age-related macular degeneration over the finish line in the US.

News

EU clears AZ's SERD camizestrant, as FDA review drags on

AstraZeneca's new breast cancer therapy Etcamah claims landmark frontline approval in the EU, but its prospects in the US are less certain.

News

Nuvalent buy delivers new cancer approval for GSK

GSK has its first approval from the $10.6bn takeover of Nuvalent, ROS1+ NSCLC therapy Jideytro, which becomes the company's first lung cancer product.

News

Takeda gets first OK for orexin narcolepsy drug, in China

China has become the first country to approve Takeda's first-in-class orexin agonist, oveporexton, for the sleep disorder narcolepsy.

Pfizer cues up vitiligo filing for Litfulo after phase 3 win

EU first to clear AbbVie's Rinvoq for alopecia areata

Outlook finally claims FDA approval for AMD drug

EU clears AZ's SERD camizestrant, as FDA review drags on

Nuvalent buy delivers new cancer approval for GSK

Takeda gets first OK for orexin narcolepsy drug, in China

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

regulatory approval

Editor's Picks